StageZero Life Sciences Ltd T.SZLS

It's not Nailoser

[4real4ever]

THE BIGGEST LOSERS HERE ARE THE SHAREHOLDERS UNFORTUNATELY

[TrippinAgain123]

This post has been removed in accordance with Community Policy

[TrippinAgain123]

This post has been removed in accordance with Community Policy

[molotov420]

unfortunately we're not even going to be told what Aristotle revenue was....they will lump it with Covid again and call it "Lab Revenue"...should see an increase in revenue though. The last quarter of Covid testing should be pretty busy due to Omicron and hopefully Sobeys brought something. If they sold any Aristotle, revs should be better than Q3

[NewToInvesting7]

I have to agree, I do not see StageZero disclosing Aristotle sales. Where I do disagree is potentially seeing an increase in Covid testing revenues for Q4.  It would be nice ot see this, but realistically, there were many other cheaper PCR testing options in the last month or two of 2021.  So unless travel ramped by 200%+ and StageZero saw an equal increase in the demand of the Covid

[NewToInvesting7]

I have no idea whether the share prices would fall or increase based on the 2021 results.  And for me, I wouldn't focus on Aristotle sales.  Before the Care acquisition, it would make perfect sense.  But now, if the 'new' company is as vertically integrated as we are told, and it does offer so much more, it would not be that meaningful to solely focus on Aristotle sales.

[NewToInvesting7]

(Sorry for the subject - was not able to edit it) Not quite the revenues I was hoping for, but not too shabby at the same time.  I was hoping for USD 5.5m, but it turned out to be slightly under USD 5.1m.  If we could carve out the Covid revenues, would give a good indication of how undervalued/overvalued the company is, but alas, that isn’t carved out. Company is moving in the right